FDA approves Amgen's copy of AbbVie arthritis drug Humira

Saturday, September 24, 2016

The US Food and Drug Administration on Friday approved Amgen Inc39s biosimilar version of AbbVie39s topselling arthritis drug Humira The drug Amjevita known also as adalimumabatto was approved to treat rheumatoid arthritis psoriatic arthritis Crohn39s disease psoriasis and other conditions Amjevit..

Novartis's Zykadia gets positive results, faces Roche pressure

Saturday, September 24, 2016

Novartis39s Zykadia drug performed well against a rare form of lung cancer the Swiss company said on Friday citing a study it hopes will help it win expanded regulatory approval for the use of the drug But it faces competition from a medicine produced by rival Roche that some analysts say may alrea..

Lundbeck says Alzheimer's drug fails in late-stage study

Friday, September 23, 2016

Danish drugmaker H Lundbeck AS39s highly anticipated experimental Alzheimer39s drug failed in a latestage study underscoring the challenges faced by drugmakers to tackle the debilitating memoryrobbing disease The Copenhagenbased company said on Thursday both doses of the drug idalopirdine showed a ..

Biostar Pharmaceuticals Signs a Letter of Intent to Acquire Xianyang Yongsheng Health Products Co., Ltd.

Friday, September 23, 2016

Biostar Pharmaceuticals Inc a PRCbased manufacturer of pharmaceutical and health supplement products and Xianyang Yongsheng Health Products Co Ltd a privately held PRCbased health product manufacturer located in Xianyang China Xianyang Yongsheng announced today that they have entered into a nonbindi..

U.S. states sue opioid-maker Indivior, alleging anticompetitive practices

Friday, September 23, 2016

Thirtyfive US states and the District of Columbia filed a lawsuit on Thursday against opioid drug maker Indivior alleging it tried to keep generic versions of a drug off the market Britishbased Indivior which was spun off from Reckitt Benckiser in 2014 is the maker of Suboxone a drug used to treat ..

Vanda Pharmaceuticals prepares to explore a sale

Friday, September 23, 2016

Vanda Pharmaceuticals Inc VNDAO a US developer of medicines for the central nervous system is preparing to consider strategic alternatives including a potential sale according to people familiar with the matter The move illustrates how Vanda is seeking to capitalize on an anticipated wave of deal m..

Evotec and Bayer partner to develop new treatments to fight kidney diseases

Thursday, September 22, 2016

Evotec AG announced that Evotec and Bayer have entered into a fiveyear multitarget research partnership The goal is the development of multiple clinical candidates for the treatment of kidney diseases such as chronic kidney disease in diabetes patients Both companies will contribute novel drug targe..

Aurobindo Pharma, Cadila recall drugs from US market

Thursday, September 22, 2016

Aurobindo Pharma and Cadila Healthcare have recalled over 25500 bottles of two different drugs in the US due to presence of foreign tablets and failed dissolution specifications Aurobindo Pharma USA Inc is recalling 23016 bottles of Pantoprazole Sodium delayedrelease tablets USP 40 mg as the firm r..

AstraZeneca pulls cancer drug application in Europe

Thursday, September 22, 2016

AstraZeneca has pulled an application seeking European approval to sell its experimental cancer drug cediranib in combination with chemotherapy to treat ovarian cancer because of latestage questions raised by regulators reviewing the product However the British company said on Wednesday that cedira..

United Nations pledges to fight drug-resistant superbugs

Thursday, September 22, 2016

United Nations member countries pledged for the first time on Wednesday to take steps to tackle the threat posed by drugresistant superbugs in a coordinated effort to curb the spread of infections by pathogens that defy antimicrobial medicines The pledge during the annual UN General Assembly in New..